Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Rubio: 'Very short window', maybe days, for Hamas to accept deal
Al Mayadeen correspondent to southern Lebanon: Israeli warplanes launched a raid on the Ksar Zaatar neighborhood in western Nabatieh.
Al Mayadeen's correspondent in Gaza: The tower destroyed by the Israeli occupation in Gaza includes media offices, including Al Mayadeen's bureau.
Al Mayadeen's correspondent in Gaza: Four fetuses and three premature babies died at Nasser Medical Complex due to malnutrition
Lebanese Ministry of Health: One person was killed in an Israeli airstrike on a car in the town of Burj Qalawieh, south Lebanon.
Al Mayadeen correspondent: The first ship of the Maghreb fleet delivering aid to break the siege on Gaza departs from the port of Gammarth in Tunisia.
Channel 12: Airspace closed at Ramon Airport due to fears of drone infiltration
IOF Spokesperson: Sirens sounded over an aircraft infiltration in the Bir Ora area, and details are being examined
Drone infiltration sirens sound north of the Gulf of Aqaba
Al Mayadeen's correspondent in Gaza: The Israeli occupation carried out five extremely violent raids on the western areas of Gaza City

New cystic fibrosis treatment may end suffering for patients

  • By Al Mayadeen English
  • Source: Agencies
  • 25 Sep 2022 14:53
4 Min Read

Trikafta/Kaftrio pill treatments are the new breakthrough in cystic fibrosis treatments as it may restore the patients' abilities to live normally again without organ transplants.

  • x
  • The triple-pill treatment (Trikafta)
    The triple-pill treatment (Trikafta)

While waiting for a lung transplant, cystic fibrosis patient David Fiant says he was on oxygen therapy and had a six-hour daily care regime, as well as three to four weeks of antibiotic infusions a year as part of his treatment that was so exhaustive he "could no longer tell if I was living to heal myself or healing myself to live."

He later became one of the first participants in the new triple-drug treatment praised as a pivotal moment for those suffering from the rare disorder, which was life-changing that when his doctor examined him after he started the therapy, he could hear air circulating in his lungs for the first time. 

Fiant described his trial with the new drug treatment, saying, "I took my first dose of the medicine one morning. By 3 pm I was feeling first effects," adding that he was able to shower by himself, climb 15 steps at once, and take his daughter "to buy comic books".

Following his triumph over his life-threatening condition, Fiant has since then become the president of the French non-profit Vaincre la Mucoviscidose (Defeat Cystic Fibrosis). Although he stated that the results were "spectacular", he underlined that a complete cure has still not been found for cystic fibrosis. 

Life expectancies at risk

The condition, which is transmitted by genetic inheritance, builds up sticky mucus in the lungs, digestive tract, and other organs leading to difficulty breathing and long-term complications, such as infection which can often be fatal. 

Related News

Heal Palestine slams US for blocking Gaza kids’ lifesaving visas

How Laura Loomer halted lifesaving medical visas for Gaza’s children

As a result, life expectancies are significantly impacted and become shorter than expected. More than 70,000 people worldwide suffer from this disease. 

Sold on the market as Trikafta in the US after its approval in 2019, its effects have proven to be major with the life expectancy of cystic fibrosis patients born between 2017 and 2021 in the US now being 53, as opposed to 38 a decade ago, according to the US non-profit organization the Cystic Fibrosis Foundation.

The triple-pill treatment was then approved by the European Union's medicines agency and by the UK in August 2020, where it was sold as Kaftrio. Both varieties have been applauded for targeting the underlying cause of the disease and repairing the mutation in the CFTR gene.

Its demand does have a downside. Out of the 7,500 cystic fibrosis patients in France, only 40% are able to use the treatment.

The reason is that the treatment has not been approved for children under the age of six, and 15% of patients have a genetic profile that the treatment won't work for. Moreover, approximately 900 individuals who received transplants of lungs or livers are also deemed ineligible.

"Do not forget us"

Sabrina Perquis, a cystic fibrosis patient in France, was excited to take the treatment until she found out that she could not use Kaftrio because of a transplant she had 15 years ago, calling it "a tough blow." 

"When you have had a transplant you live with a sword of Damocles hanging over your head because rejection is always possible," she said, adding, "We are asking not to be forgotten. Research must continue to find a solution for all patients."

Although several research studies are taking place and are at varying stages of development, questions still remain, such as whether the treatment completely blocks the disease's development or if it solely impedes it, according to Vaincre la Mucoviscidose Vice-President Pierre Foucaud. 

Cystic fibrosis patients who had an organ transplant fell from 21 to just 2 per quarter in France from the years 2019 to 2021, fueled by hopes that the Kaftrio treatment would make the transplant operation unnecessary. "But will these transplants merely be delayed by 10 to 15 years?" Foucaud asked. "We don't know," adding that Kaftrio has "opened up a tremendous hope for all patients" but more work needs to be conducted. 

  • Medical treatment
  • US
  • cystic fibrosis
  • European Union

Most Read

The damaged building in the Katara neighborhood, Doha, Qatar, September 9, 2025 (Social media)

Hamas delegation survives Israeli assassination attempt in Qatar

  • Politics
  • 9 Sep 2025
Pro-"Israel" conservative Charlie Kirk shot during Utah speech

American far-right activist Charlie Kirk shot dead during Utah speech

  • US & Canada
  • 11 Sep 2025
Uprising against Volker Turk at the Human Rights Council over Gaza.

Uprising against Volker Turk at the Human Rights Council over Gaza

  • Politics
  • 12 Sep 2025
A screengrab from the ad played on Fox News. (X Screengrab)

Fox airs ad warning Trump not to let Netanyahu 'play' him on Gaza

  • US & Canada
  • 11 Sep 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
President Nicolas Maduro gestures to supporters during the inauguration of a monument in China's honor on the 80th anniversary of the end of World War II, in Caracas, Venezuela, Wednesday, September 3, 2025 (AP)
Politics

Maduro warns of threats, urges 'battle for truth' to defend Venezuela

Damage is seen after an Israeli strike targeted a compound that hosted Hamas' political leadership in Doha, Qatar, Wednesday, Sept. 10, 2025. (AP Photo/Jon Gambrell)
Politics

Netanyahu informed Trump before deadly attack in Doha: Reports

Israeli Prime Minister Benjamin Netanyahu and US Secretary of State Marco Rubio hold a joint press conference at the Prime Minister's Office, during Rubio's visit, in occupied al-Quds, occupied Palestine, Monday, September 15, 2025 (AP)
Politics

Netanyahu warns of Israeli isolation, calls to boost self-reliance

Spain axes €700Mln arms deals with 'Israel' over Gaza genocide
Politics

Spain axes €700 mln arms deals with 'Israel' over Gaza genocide

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS